Gefitinib as First-line Treatment in Elderly Epidermal Growth Factor Receptor-mutated Patients With Advanced Lung Adenocarcinoma: Results of a Nagano Lung Cancer Research Group Study

First-line treatment with gefitinib was effective and well-tolerated in elderly patients with EGFR mutations.